Form D · Investing
Corbus Pharmaceuticals Holdings, Inc.
New York, NY · CIK 0001595097
Offering snapshot reported Apr 23, 2014 · SEC filing
- Reported sold
- $6.31M Offering amount: $13M
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 11, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2014 | Initial | $6,310,000 | No comparison | 45 | SEC filing |
| Mar 12, 2014 | Initial | $19,750 | No comparison | 3 | SEC filing |
| Jan 10, 2014 | Initial | $90,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $1.3M (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-216074
Reflects only private placement consideration. Contemporaneously with the merger, we completed a private placement of stock and warrants. Includes over allotment option.
Placement Agent is entitled to receive 10% cash and certain non cash consideration based on the aggregate amount sold in the offering. Estimated amount of sales commissions assumes maximum offering sold. Includes fees paid on over allotment option.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corp. | 15007 |
Source: Form D, filed Apr 23, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Brancaccio | Executive |
| Yuval Cohen | Director, Executive |
| David Hochman | Director |
| Alan Holmer | Director |
| Sean Moran | Executive |
| Mark Tepper | Executive |
| Robert Zurier | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
142 West 57 Th Street Suite 4 A
New York, NY, 10019
New York, NY, 10019